Novozymes A/S (OTCMKTS:NVZMY) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $66.35 and traded as low as $63.5440. Novozymes A/S shares last traded at $64.42, with a volume of 36,641 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research lowered Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Novozymes A/S presently has an average rating of “Buy”.

Check Out Our Latest Research Report on Novozymes A/S

Novozymes A/S Trading Down 1.3%

The company has a debt-to-equity ratio of 0.28, a current ratio of 1.75 and a quick ratio of 1.07. The firm has a market capitalization of $30.17 billion, a PE ratio of 38.12, a P/E/G ratio of 1.15 and a beta of 0.96. The company’s fifty day simple moving average is $62.25 and its 200-day simple moving average is $66.35.

Novozymes A/S Cuts Dividend

The business also recently declared a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were paid a $0.1856 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S’s dividend payout ratio (DPR) is currently 21.89%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Further Reading

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.